InsiderClue
← All stocks

Mereo BioPharma Group plc

MREO Net selling
CIK 0001719714 #4717 in the set updated 22 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.08M
$0.00 on a plan · $764.00K straight out of an exercise
Sold at will
$2.32M
22 of 25 sales
Net
−$3.08M
−$2.32M against sales at will

By person

8 insiders · 27 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hughes-Wilson Alexandra
See Remarks
—
$1.05M (8)
−$1.05M
50,475
0.0063%
$213.05K
—
Scots-Knight Denise
Chief Executive Officer
—
$844.91K (4)
−$844.91K
808,921
0.1013%
$3.41M
+44.3%
PAKIANATHAN DEEPIKA
Director
—
$466.21K (1) scheduled
−$466.21K
0
0.0000%
$0.00
—
Sermon Charles
General Counsel
—
$294.73K (4)
−$294.73K
219,061
0.0274%
$924.66K
+65.5%
Fox Christine Ann
Chief Financial Officer
—
$269.57K (4)
−$269.57K
89,285
0.0112%
$376.87K
+792.8%
Lewicki John A.
Chief Scientific Officer
—
$153.90K (4)
−$153.90K
78,630
0.0098%
$331.90K
+1,864%
WYZGA MICHAEL S
Director
—
—
—
25,050
0.0031%
$105.74K
—
Bender Jeremy
Director
—
—
—
12,550
0.0016%
$52.97K
—

Individual transactions

22
Insider
Date
Role
Action
Shares
Price
Amount
Hughes-Wilson Alexandra
13 Sep 2024
See Remarks
Sell
84,008
$4.22
$354.60K
Hughes-Wilson Alexandra
13 Sep 2024
See Remarks
Sell
16,304
$4.22
$68.82K
Fox Christine Ann
13 Sep 2024
Chief Financial Officer
Sell
19,158
$4.22
$80.87K
Sermon Charles
13 Sep 2024
General Counsel
Sell
20,946
$4.22
$88.41K
Lewicki John A.
13 Sep 2024
Chief Scientific Officer
Sell
10,937
$4.22
$46.17K
Scots-Knight Denise
13 Sep 2024
Chief Executive Officer
Sell
60,046
$4.22
$253.45K
Hughes-Wilson Alexandra
12 Sep 2024
See Remarks
Sell
40,029
$4.47
$179.04K
Hughes-Wilson Alexandra
12 Sep 2024
See Remarks
Sell
7,769
$4.47
$34.75K
Fox Christine Ann
12 Sep 2024
Chief Financial Officer
Sell
9,128
$4.47
$40.83K
Sermon Charles
12 Sep 2024
General Counsel
Sell
9,980
$4.47
$44.64K
Lewicki John A.
12 Sep 2024
Chief Scientific Officer
Sell
5,212
$4.47
$23.31K
Scots-Knight Denise
12 Sep 2024
Chief Executive Officer
Sell
28,611
$4.47
$127.97K
Hughes-Wilson Alexandra
26 Jun 2024
See Remarks
Sell
22,968
$3.39
$77.94K
Scots-Knight Denise
26 Jun 2024
Chief Executive Officer
Sell
92,273
$3.39
$313.10K
Fox Christine Ann
26 Jun 2024
Chief Financial Officer
Sell
29,439
$3.39
$99.89K
Lewicki John A.
26 Jun 2024
Chief Scientific Officer
Sell
16,808
$3.39
$57.03K
Sermon Charles
26 Jun 2024
General Counsel
Sell
32,187
$3.39
$109.22K
Hughes-Wilson Alexandra
25 Jun 2024
See Remarks
Sell
10,134
$3.69
$37.43K
Scots-Knight Denise
25 Jun 2024
Chief Executive Officer
Sell
40,712
$3.69
$150.39K
Fox Christine Ann
25 Jun 2024
Chief Financial Officer
Sell
12,990
$3.69
$47.98K
Lewicki John A.
25 Jun 2024
Chief Scientific Officer
Sell
7,416
$3.69
$27.39K
Sermon Charles
25 Jun 2024
General Counsel
Sell
14,202
$3.69
$52.46K
Show all 27 transactions →

What was left out

Form 4 filings counted 64
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 1,546,561
History held since 26 Jan 2024